1 of 18

2022 Update to Canadian Acute Stroke �Best Practices Recommendations�

Rhonda Whiteman, R.N., MN, CNN (C)

Clinical Nurse Specialist - Central South Regional Stroke Network

September 14, 2023

2 of 18

Impact of Stroke in Canada

108,707

strokes/year

Someone has a stroke

every 5 minutes

20% chance of

second stroke

within 2 years

Risk of stroke

doubles every year

over the

age of 65 years

Having a stroke more than doubles the risk of developing dementia

Leading cause of

adult disability

Third leading cause of death

More than 878.000 Canadians

are living with stroke

Strokes are increasing younger adults aged

20 – 59 years

1 in 3 Canadians will develop stroke, dementia or both

3 of 18

2022 Canadian Stroke Acute Best Practice Recommendations (CSBPR) Update

Two Phases of Care for all stroke subtypes:

  • Prehospital and Emergency Department Acute Stroke Care:
    • “Hyperacute” Time Sensitive Window – �First 24 hours
  • Acute Stroke Care:
    • Discharge from acute care or first 30 days

https://www.strokebestpractices.ca/recommendations/acute-stroke-management

4 of 18

CSBPR Section 1 - Stroke Awareness, �Recognition & Response

    • Organized systems of care established to enable rapid emergency stroke management

    • Education that stroke is a medical emergency that can affect persons of any age - Newborns, Children and Adults

    • Awareness campaigns and Recognition of signs of stroke (FAST) and immediate Response by calling 911

5 of 18

CSBPR Section 2 – Triage and Initial Diagnostic Evaluation of TIA/Non Disabling Stroke

Highest Risk for Recurrent Stroke

Pts within 48 hours of symptom onset

Transient motor, speech or persistent symptoms

Immediately sent to ED with capacity for stroke care

After 48 hours

Need comprehensive evaluation and brain imaging ASAP

Stroke Prevention Clinics provide rapid access to stroke experts, investigations, risk factor management

Vertebrobasilar Ischemia

Diplopia, dysarthria, dysphagia, vertigo, ataxia may occur for greater than 48 hours

Can be mistaken as stroke mimics and need urgent evaluation and brain imaging

6 of 18

CSBPR Section 3 – Emergency Medical Management of Acute Stroke

Prehospital Phase

Emergency Department Phase

Interhospital Transfer Time

7 of 18

CSBPR Section 3 – Emergency Medical Management of Acute Stroke

Handover in Emergency Department

    • Rapid TOA and patients within window have highest priority in ED Triage

    • TOA in ED to facilitate Acute Stroke Treatment Decision Making:
      • Onset or Last Known Well
      • Presenting symptoms
      • Current status
      • Baseline Functional Status and independence level
      • Current medications (especially anticoagulants) and time take
      • Advanced care plans
      • Additional health concerns

Transport of Suspected Stroke Patients

    • Direct Transport Protocols should be in place to facilitate transfer of stroke patients eligible for acute stroke therapy to acute stroke hospitals
    • Triage as CTAS Level 2 or Level 1 if compromised ABC’s
    • Pre-Notification to ED including LKW, S&S, LAMS score, ETA to hospital
    • Patient outside of acute stroke treatment window transported to closest hospital
    • System of rapid transport should be available to facilitate the movement of pts from one ED to another for time sensitive stroke treatment (Walk In Protocols, Transport for EVT, etc.)

Paramedic On Scene Treatment

    • PreHospital Stroke Screening Tool
    • Screening for Large Vessel Occlusion (LVO) stroke on scene
    • Limit treatments on scene to immediately needed
    • History from witness
    • On-scene time less than 20 minutes
    • Capillary glucose
    • Instruct family to be accessible to hospital either in person or via phone

Access to Emergency Medical Services

    • 911

    • Central Ambulance Communication Centres

    • Dispatch communication to paramedics

8 of 18

9 of 18

CSBPR - Mobile Stroke Units �(Stroke Ambulances)

CSBPR is could not make a recommendations about mobile stroke units as published data in Canadian context and health system organization is lacking.

High quality studies in other countries suggest use of mobile stroke units is associated with reduced time to thrombolysis, increased proportion of patients requiring thrombolysis and better functional outcomes at 90 days.

10 of 18

CSBPR Section 4 – Emergency Department Evaluation and Management of TIA/Acute Stroke�Initial ED Evaluation of suspected stroke patients

Immediately assessed and undergo diagnostic investigations to determine eligibility for Hyperacute Stroke Treatments

Rapid Neurological Examination and assessment of vitals signs, heart rhythm and presence of seizures

Acute stroke bloodwork and Brain Imaging

11 of 18

CSBPR 4.2 Neurovascular Imaging�Within 6 Hours

Non Contrast CT Head

  • First Line diagnostic tool for patients with suspected neurological conditions
  • Looking for areas of infarction or bleeding in the brain
  • Identify eligibility for stroke thrombolysis

Multiphase CT Angiogram

  • Identify Large Vessel Ischemic Stroke who are eligible for EVT
  • Head and Neck
  • Used to evaluate collateral circulation in brain
  • Requires Contrast – Large Bore IV

11

12 of 18

CSBPR 4.2 Neurovascular Imaging�6 - 24 Hours

  • Stroke patients within 6 to 24 hours including stroke on awakening or with unknown onset time who are potentially eligible for EVT should undergo CT Head, CTA and CT Perfusion

  • CTP assess cerebral blood flow to identify areas of reduced cerebral blood flow in acute ischemic stroke

  • Provides clear, easy to interpret maps �which quantifies cerebral blood flow and volumes to identify patient eligible for EVT

  • Requires CT Contrast – Large Bore IV

13 of 18

CSBPR Section 5 – Acute Ischemic �Stroke Treatment

All stroke patients with disabling ischemic stroke symptoms within 6 hours should be screened without delay by a physician with stroke expertise for eligibility for intravenous thrombolysis or interventional treatment with EVT.

All patients with disabling stroke symptoms between 6 to 24 hours should be rapidly screened to determine eligibility for advanced imaging and acute stroke treatments.

Use of intravenous thrombolysis and/or EVT in patients who are not functionally independent may be considered weighing risks and benefits for the patient.

14 of 18

CSBPR 5.2 Intravenous Thrombolysis Administration

  • All eligible patients with disabling ischemic stroke, who can receive intravenous thrombolysis with alteplase or tenecteplase within 4.5 hours of stroke symptom onset/last known well should be offered it.

  • All eligible patients should receive intravenous thrombolysis as soon as possible , with a median Door-to-Needle time of 30 minutes or less, and a Door-to-Needle time of 60 minutes or less in at least 90% of treated patients.”

  • Tenecteplase may be considered an alternate to alteplase within 4.5 hours of acute stroke onset.
    • Single bolus dose of 0.25 mg/kg up to a maximum of 25 mg

15 of 18

AcT Trial (Alteplase compared to Tenecteplase)

  • AcT Trial found the Tenecteplase was non-inferior to Alteplase in terms of functional outcomes and risk of complications:
    • 37% had functional improvement at 90 days
    • Symptomatic ICH rates were same – 3.4%
    • Systematic Hemorrhage were rare – 1%
    • Angioedema was rare – 1%

  • Why switch to TNK?
    • Easy to administer as a one time bolus
      • TPA is a Bolus over 1 minute followed by infusion over 1 hour
    • No need for an infusion pump
    • Simplified dosing – less likelihood of dosing errors

16 of 18

CSBPR 5.4 Endovascular Therapy for Acute Ischemic Stroke

  • 5.4.1 Anterior Circulation:
    • For large artery occlusions in anterior circulation, EVT should be considered based on patient pre-morbid function, clinical deficit and imaging findings. Patients who can be treated within 6 hours of symptom onset should be receive EVT

    • Selected patients with Large artery occlusion and who are eligible based on premorbid status and advanced neuroimaging, should be treated with EVT within 24 hours of last known well

  • 5.4.2 Posterior Circulation:
    • For large artery occlusions in the posterior circulation (basilar artery occlusion) EVT should be considered based on patient pre-morbid function, clinical deficit and imaging findings.

17 of 18

Benefits of Endovascular Therapy

  • Benefits of EVT – 24% have a positive outcome

  • NNT = 4 (to live independently)

  • Risk of ICH = 3%

18 of 18

Questions

Rhonda Whiteman

mcnicolr@hhsc.ca